Skip to main content
Erschienen in: Journal of Genetic Counseling 4/2014

01.08.2014 | Next Generation Genetic Counseling

Traditional Roles in a Non-Traditional Setting: Genetic Counseling in Precision Oncology

verfasst von: Jessica N. Everett, Shanna L. Gustafson, Victoria M. Raymond

Erschienen in: Journal of Genetic Counseling | Ausgabe 4/2014

Einloggen, um Zugang zu erhalten

Abstract

Next generation sequencing technology is increasingly utilized in oncology with the goal of targeting therapeutics to improve response and reduce side effects. Interpretation of tumor mutations requires sequencing of paired germline DNA, raising questions about incidental germline findings. We describe our experiences as part of a research team implementing a protocol for whole genome sequencing (WGS) of tumors and paired germline DNA known as the Michigan Oncology Sequencing project (MI-ONCOSEQ) that includes options for receiving incidental germline findings. Genetic counselors (GCs) discuss options for return of results with patients during the informed consent process and document family histories. GCs also review germline findings and actively participate in the multi-disciplinary Precision Medicine Tumor Board (PMTB), providing clinical context for interpretation of germline results and making recommendations about disclosure of germline findings. GCs have encountered ethical and counseling challenges with participants, described here. Although GCs have not been traditionally involved in molecular testing of tumors, our experiences with MI-ONCOSEQ demonstrate that GCs have important applicable skills to contribute to multi-disciplinary care teams implementing precision oncology. Broader use of WGS in oncology treatment decision making and American College of Medical Genetics and Genomics (ACMG) recommendations for active interrogation of germline tissue in tumor-normal dyads suggests that GCs will have future opportunities in this area outside of research settings.
Literatur
Zurück zum Zitat Berg, J. S., Adams, M., Nassar, N., Bizon, C., Lee, K., Schmitt, C. P., et al. (2013). An informatics approach to analyzing the incidentalome. Genetics in Medicine, 15(1), 36–44.CrossRef Berg, J. S., Adams, M., Nassar, N., Bizon, C., Lee, K., Schmitt, C. P., et al. (2013). An informatics approach to analyzing the incidentalome. Genetics in Medicine, 15(1), 36–44.CrossRef
Zurück zum Zitat Bombard, Y., Robson, M., & Offit, K. (2013). Revealing the incidentalome when targeting the tumor genome. JAMA, 310(8), 795–796.CrossRef Bombard, Y., Robson, M., & Offit, K. (2013). Revealing the incidentalome when targeting the tumor genome. JAMA, 310(8), 795–796.CrossRef
Zurück zum Zitat Catt, S., Langridge, C., Fallowfield, L., Talbot, D. C., & Jenkins, V. (2011). Reasons given by patients for participating, or not, in Phase 1 cancer trials. European Journal of Cancer, 47(10), 1490–1497.CrossRef Catt, S., Langridge, C., Fallowfield, L., Talbot, D. C., & Jenkins, V. (2011). Reasons given by patients for participating, or not, in Phase 1 cancer trials. European Journal of Cancer, 47(10), 1490–1497.CrossRef
Zurück zum Zitat Dancey, J. E., Bedard, P. L., Onetto, N., & Hudson, T. J. (2012). The genetic basis for cancer treatment decisions. Cell, 148(3), 409–420.CrossRef Dancey, J. E., Bedard, P. L., Onetto, N., & Hudson, T. J. (2012). The genetic basis for cancer treatment decisions. Cell, 148(3), 409–420.CrossRef
Zurück zum Zitat Daugherty, C., Ratain, M. J., Grochowski, E., Stocking, C., Kodish, E., Mick, R., et al. (1995). Perceptions of cancer patients and their physicians involved in phase I trials. Journal of Clinical Oncology, 13(5), 1062–1072.CrossRef Daugherty, C., Ratain, M. J., Grochowski, E., Stocking, C., Kodish, E., Mick, R., et al. (1995). Perceptions of cancer patients and their physicians involved in phase I trials. Journal of Clinical Oncology, 13(5), 1062–1072.CrossRef
Zurück zum Zitat Green, R. C., Berg, J. S., Grody, W. W., Kalia, S. S., Korf, B. R., Martin, C. L., et al. (2013). ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genetics in Medicine, 15(7), 565–574.CrossRef Green, R. C., Berg, J. S., Grody, W. W., Kalia, S. S., Korf, B. R., Martin, C. L., et al. (2013). ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genetics in Medicine, 15(7), 565–574.CrossRef
Zurück zum Zitat Halpern, S. D., Ubel, P. A., & Asch, D. A. (2007). Harnessing the power of default options to improve health care. New England Journal of Medicine, 357(13), 1340–1344.CrossRef Halpern, S. D., Ubel, P. A., & Asch, D. A. (2007). Harnessing the power of default options to improve health care. New England Journal of Medicine, 357(13), 1340–1344.CrossRef
Zurück zum Zitat Johnston, J. J., Rubinstein, W. S., Facio, F. M., Ng, D., Singh, L. N., Teer, J. K., et al. (2012). Secondary variants in individuals undergoing exome sequencing: screening of 572 individuals identifies high-penetrance mutations in cancer-susceptibility genes. The American Journal of Human Genetics, 91(1), 97–108.CrossRef Johnston, J. J., Rubinstein, W. S., Facio, F. M., Ng, D., Singh, L. N., Teer, J. K., et al. (2012). Secondary variants in individuals undergoing exome sequencing: screening of 572 individuals identifies high-penetrance mutations in cancer-susceptibility genes. The American Journal of Human Genetics, 91(1), 97–108.CrossRef
Zurück zum Zitat Mand, C., Gillam, L., Delatycki, M. B., & Duncan, R. E. (2012). Predictive genetic testing in minors for late-onset conditions: a chronological and analytical review of the ethical arguments. Journal of Medical Ethics, 38(9), 519–524.CrossRef Mand, C., Gillam, L., Delatycki, M. B., & Duncan, R. E. (2012). Predictive genetic testing in minors for late-onset conditions: a chronological and analytical review of the ethical arguments. Journal of Medical Ethics, 38(9), 519–524.CrossRef
Zurück zum Zitat Mazoyer, S., Dunning, A. M., Serova, O., Dearden, J., Puget, N., Healey, C. S., et al. (1996). A polymorphic stop codon in BRCA2. Nature Genetics, 14(3), 253–254.CrossRef Mazoyer, S., Dunning, A. M., Serova, O., Dearden, J., Puget, N., Healey, C. S., et al. (1996). A polymorphic stop codon in BRCA2. Nature Genetics, 14(3), 253–254.CrossRef
Zurück zum Zitat Nickel, P. J. (2006). Vulnerable populations in research: the case of the seriously ill. Theoretical Medicine and Bioethics, 27(3), 245–264.CrossRef Nickel, P. J. (2006). Vulnerable populations in research: the case of the seriously ill. Theoretical Medicine and Bioethics, 27(3), 245–264.CrossRef
Zurück zum Zitat O’Neill, S. M., Peters, J. A., Vogel, V. G., Feingold, E., & Rubinstein, W. S. (2006). Referral to cancer genetic counseling: are there stages of readiness? American Journal of Medical Genetics Part C: Seminars in Medical Genetics, 142C(4), 221–231.CrossRef O’Neill, S. M., Peters, J. A., Vogel, V. G., Feingold, E., & Rubinstein, W. S. (2006). Referral to cancer genetic counseling: are there stages of readiness? American Journal of Medical Genetics Part C: Seminars in Medical Genetics, 142C(4), 221–231.CrossRef
Zurück zum Zitat Pellegrini, I., Rapti, M., Extra, J. M., Petri-Cal, A., Apostolidis, T., Ferrero, J. M., et al. (2012). Targeted chemotherapy for breast cancer: patients perception of the use of tumor gene profiling approaches to better adapt treatments. Medical Science (Paris), 28 Spec No 1, 24–27. Pellegrini, I., Rapti, M., Extra, J. M., Petri-Cal, A., Apostolidis, T., Ferrero, J. M., et al. (2012). Targeted chemotherapy for breast cancer: patients perception of the use of tumor gene profiling approaches to better adapt treatments. Medical Science (Paris), 28 Spec No 1, 24–27.
Zurück zum Zitat Points to consider: ethical, legal, and psychosocial implications of genetic testing in children and adolescents. American Society of Human Genetics Board of Directors, American College of Medical Genetics Board of Directors. (1995). American Journal of Human Genetics, 57(5), 1233–1241. Points to consider: ethical, legal, and psychosocial implications of genetic testing in children and adolescents. American Society of Human Genetics Board of Directors, American College of Medical Genetics Board of Directors. (1995). American Journal of Human Genetics, 57(5), 1233–1241.
Zurück zum Zitat Richman, A. R., Tzeng, J. P., Carey, L. A., Retel, V. P., & Brewer, N. T. (2011). Knowledge of genomic testing among early-stage breast cancer patients. Psychooncology, 20(1), 28–35.CrossRef Richman, A. R., Tzeng, J. P., Carey, L. A., Retel, V. P., & Brewer, N. T. (2011). Knowledge of genomic testing among early-stage breast cancer patients. Psychooncology, 20(1), 28–35.CrossRef
Zurück zum Zitat Roychowdhury, S., Iyer, M. K., Robinson, D. R., Lonigro, R. J., Wu, Y. M., Cao, X., et al. (2011). Personalized oncology through integrative high-throughput sequencing: a pilot study. Science Translational Medicine, 3(111), 111ra121.CrossRef Roychowdhury, S., Iyer, M. K., Robinson, D. R., Lonigro, R. J., Wu, Y. M., Cao, X., et al. (2011). Personalized oncology through integrative high-throughput sequencing: a pilot study. Science Translational Medicine, 3(111), 111ra121.CrossRef
Zurück zum Zitat Seidenfeld, J., Horstmann, E., Emanuel, E. J., & Grady, C. (2008). Participants in phase 1 oncology research trials: are they vulnerable? Archives of Internal Medicine, 168(1), 16–20.CrossRef Seidenfeld, J., Horstmann, E., Emanuel, E. J., & Grady, C. (2008). Participants in phase 1 oncology research trials: are they vulnerable? Archives of Internal Medicine, 168(1), 16–20.CrossRef
Zurück zum Zitat Sharaf, R. N., Myer, P., Stave, C. D., Diamond, L. C., & Ladabaum, U. (2013). Uptake of genetic testing by relatives of Lynch syndrome probands: a systematic review. Clinical Gastroenterology and Hepatology, 11(9), 1093–1100.CrossRef Sharaf, R. N., Myer, P., Stave, C. D., Diamond, L. C., & Ladabaum, U. (2013). Uptake of genetic testing by relatives of Lynch syndrome probands: a systematic review. Clinical Gastroenterology and Hepatology, 11(9), 1093–1100.CrossRef
Zurück zum Zitat Tait, A. R., Voepel-Lewis, T., & Malviya, S. (2003). Do they understand? (part I): parental consent for children participating in clinical anesthesia and surgery research. Anesthesiology, 98(3), 603–608.CrossRef Tait, A. R., Voepel-Lewis, T., & Malviya, S. (2003). Do they understand? (part I): parental consent for children participating in clinical anesthesia and surgery research. Anesthesiology, 98(3), 603–608.CrossRef
Metadaten
Titel
Traditional Roles in a Non-Traditional Setting: Genetic Counseling in Precision Oncology
verfasst von
Jessica N. Everett
Shanna L. Gustafson
Victoria M. Raymond
Publikationsdatum
01.08.2014
Verlag
Springer US
Erschienen in
Journal of Genetic Counseling / Ausgabe 4/2014
Print ISSN: 1059-7700
Elektronische ISSN: 1573-3599
DOI
https://doi.org/10.1007/s10897-014-9698-3

Weitere Artikel der Ausgabe 4/2014

Journal of Genetic Counseling 4/2014 Zur Ausgabe

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.